Search company, investor...
North Shore InnoVentures company logo

North Shore InnoVentures

Founded Year



Grant - III | Alive

Total Raised


Last Raised

$1.65M | 9 yrs ago

About North Shore InnoVentures

North Shore InnoVentures (NSIV) is a non-profit 501(c) (3) business incubator headquartered at the burgeoning cluster of more than sixty life sciences and cleantech businesses at the Cummings Center in Beverly, MA. NSIV is dedicated to accelerating the growth of innovative early-stage life sciences and cleantech businesses and supporting the economic growth of Boston's North Shore. Its management, board of directors, advisory board, and mentors bring a wealth of entrepreneurship experience in addition to business development and technical expertise.

Headquarters Location

Beverly, Massachusetts, 01915,

United States

Missing: North Shore InnoVentures's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: North Shore InnoVentures's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest North Shore InnoVentures News

North Shore InnoVentures Chosen as International Soft Landing Center

Nov 7, 2018

Beverly-based incubator chosen as only international soft landing center in New England; Offers specialized services to foreign biotech and cleantech companies establishing US operations November 07, 2018 10:00 AM Eastern Standard Time BEVERLY, Mass.--( BUSINESS WIRE )-- North Shore InnoVentures (NSIV), a non-profit technology business incubator helping biotech and cleantech startups increase their probability of success, earned recognition as part of the Global Soft Landing Network by the International Business Innovation Association (InBIA) . NSIV is the only location in New England to join the highly-selective program, which identifies incubators around the world that are expert in addressing the needs of companies expanding into new national markets. International entrepreneurs face huge challenges as they look to enter the US market. In addition to the technological and business challenges that plague every eager entrepreneur, they also often find cultural and market differences that hamper growth. What they need is a place to start that offers them a chance to get to know the market while also providing the business mentorship they need to succeed. “A company cannot simply apply what they know in their home market to what goes on here. They need specific help to solve complex problems,” said NSIV CEO Chris Ilsley. “Each company’s challenge is unique and they need unique mentorship to help them solve it. For one company it could be as simple as giving samples to prospective customers, which seems so natural to a company marketing in the US but is a new concept in some business cultures. For other companies the problems could be in navigating regulatory and compliance issues, or even understanding fragmented and localized markets that exist across the US.” Foreign investment has a huge impact in Massachusetts This isn’t just about entrepreneurship, but about boosting local economic impact with foreign investment. Foreign direct investment in the US totaled $259.6 billion in 2017, according to the US Bureau of Economic Analysis . Of that, $6.4 billion focused specifically on establishing and expanding foreign businesses. Here in Massachusetts, nearly 7 percent of private industry employees work for companies that are foreign owned , accounting for more than 200,00 jobs . “International companies need help in a myriad of different areas, from legal assistance around issues like immigration, intellectual property and import/ export issues, to cultural training, housing assistance and access to capital,” said Charles Ross, InBIA’s interim president and CEO. “NSIV is the rare location that has a long history of helping such companies across all categories of need.” The Soft Landing designation comes amid a year of growth and expansion for NSIV. Celebrating its first decade, the incubator recently hired a new CEO and expanded its footprint at the Cummings Center in Beverly. Its newly-opened 13,000 square foot facility includes co-working, wet labs and a maker space. In addition, the Cummings Foundation awarded NSIV a 10-year, $200,000 sustaining grant, and InBIA previously recognized NSIV by naming it the Dinah Adkins Technology Incubator of the Year . Since its inception, NSIV has incubated 44 companies that have created 295 jobs, many of which remain in the North Shore of Massachusetts. ABOUT the International Business Innovation Association (InBIA) InBIA is a global nonprofit with over 2,200 members that lead hundreds of entrepreneurship centers in 62 countries. For over 30 years, InBIA has provided industry best practices through education while enabling collaboration, mentorship, peer-based learning and the sharing of innovative ideas for developing entrepreneur centers and ecosystems across the globe. InBIA is the premier organization for business incubators, accelerators, coworking spaces and other entrepreneurship support organizations. About NSIV North Shore InnoVentures (NSIV) is a non-profit 501(c)(3) business incubator headquartered in the burgeoning cluster of more than sixty life sciences and cleantech businesses at the Cummings Center in Beverly, MA. NSIV is dedicated to accelerating the growth of innovative early-stage life sciences and cleantech businesses and supporting the economic growth of Boston North. Its management, board of directors, advisory board, and mentors bring a wealth of entrepreneurship experience in addition to business development and technical expertise. Further support comes from sponsors who contribute marketing, legal, operational and educational services. For more information, visit .

North Shore InnoVentures Frequently Asked Questions (FAQ)

  • When was North Shore InnoVentures founded?

    North Shore InnoVentures was founded in 2008.

  • Where is North Shore InnoVentures's headquarters?

    North Shore InnoVentures's headquarters is located at Beverly.

  • What is North Shore InnoVentures's latest funding round?

    North Shore InnoVentures's latest funding round is Grant - III.

  • How much did North Shore InnoVentures raise?

    North Shore InnoVentures raised a total of $1.81M.

  • Who are the investors of North Shore InnoVentures?

    Investors of North Shore InnoVentures include Massachusetts Life Sciences Center, Massachusetts Clean Energy Center and Cummings Foundation.

  • Who are North Shore InnoVentures's competitors?

    Competitors of North Shore InnoVentures include Horizon Technology Finance and 4 more.

Compare North Shore InnoVentures to Competitors

Cambridge Innovation Center Logo
Cambridge Innovation Center

Cambridge Innovation Center (CIC) specializes in building and operating campuses that support the growth of entrepreneurs and startups. Its collaborative work environments support individuals in the for-profit and nonprofit sectors who are focused on solutions to local and global problems. It was founded in 1999 and is based in Cambridge, Massachusetts.

ProteoGen Bio S.r.l.

ProteoGen Bio aims to join research and market in the fields of bioinformatics and biotechnology. Established in September 2003 as a spin-off company of the University of Pisa, with its expertise in different areas, and a interdisciplinary approach, ProteoGen Bio is developing technologies for helping modern molecular biology in its multi-purpose applications: from diagnostics to biomedicine, from mass spectrometry to environmental conservation.


Recoly N.V., a Netherlands Antilles based biotechnology company, is in the business of developing or acquiring platform technologies for use in the health care industry. Through the efforts of its research and development team, Recoly has developed a patented, platform technology which has been shown to prolong the half-life and improve the biological efficacy of protein and peptide pharmaceuticals by formulating them with PEGylated liposomes. The proteins and peptides bind non-covalently and yet with high affinity to the external surface of the liposomes; the proteins and peptides maintain their biological activity. No change in the protein/peptide manufacturing process is required. Recoly's business model is to partner with pharmaceutical and biotechnology companies to develop improvements of approved pharmaceutical products and thereby extend product franchises and enlarge product pipelines.


Welgen, Inc. is a biotech company developing technologies and products for biomedical research. The company was founded in 2002 to develop vectors for gene delivery and silencing that facilitate research activities in both academia and industry. The company's products provide the medical research community and the pharmaceutical industry with rapid and cost-efficient approaches for gene function research and drug development.

Global Cell Solutions

Global Cell Solutions, headquartered in Charlottesville, Virginia, is focused on the application of a improved patent-pending cell culturing technique. Global Cell is positioned to be an integral partner to scientific s in medicine, research, biotechnology, pharmaceuticals and the emerging field of orthobiologics.

Harihar Biotech Logo
Harihar Biotech

Harihar Biotech is a North India based biotechnology company and is a part of HH Bio group, with special focus on Plant Tissue Culture.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.